Literature DB >> 32091305

Perioperative Outcomes of Single vs Multi-Port Robotic Assisted Radical Prostatectomy: A Single Institutional Experience.

Ava Saidian1, Andrew M Fang1, Ornin Hakim2, Cristina Magi-Galluzzi3, Jeffrey W Nix1,4, Soroush Rais-Bahrami1,4,5.   

Abstract

PURPOSE: Surgical approach to radical prostatectomy has evolved due to advances in minimally invasive surgery, with most contemporary approaches involving the Si or Xi multi-port robotic systems. U.S. Food and Drug Administration approval of the single-port da Vinci® SP robotic platform has led to a few case series suggesting its safety and feasibility for robotic assisted radical prostatectomy in patients with prostate cancer. However, there are no established data on perioperative outcomes comparing single-port to multi-port robotic approaches to robot-assisted radical prostatectomy.
MATERIALS AND METHODS: All patients who underwent robot-assisted radical prostatectomy by 2 urological surgeons at our institution between October 2018 and June 2019 were retrospectively reviewed. The available preoperative clinical and demographic data, operative parameters and postoperative outcomes were collected and analyzed using the t-test, chi-square and Fisher exact statistical measures.
RESULTS: Overall 95 patients who underwent robot-assisted radical prostatectomy at our institution were included in our study, with 47 single-port and 48 multi-port. Preoperative clinical parameters including age, body mass index, prior abdominal surgery and biopsy grade group were similar across the 2 groups. No differences in estimated blood loss (169.2±114.2 vs 157.7±125.4 ml, p=0.64), operative time (255.9±44.1 vs 274.7±50.4 minutes, p=0.06), length of hospitalization (1.1±0.5 vs 1.4±1.1 days, p=0.17), rate of perioperative inpatient Clavien-Dindo complications 2 or greater (4.3% vs 6.3% p=0.66) and rate of positive pathological margin (21.3% vs 27.1%, p=0.51) were noted comparing the single-port and multi-port approaches, respectively.
CONCLUSIONS: The single-port robotic system allows a feasible approach to robot-assisted radical prostatectomy and has operative and perioperative outcomes comparable to those of the well accepted multi-port robotic approach.

Keywords:  minimally invasive surgical procedures; prostatectomy; prostatic neoplasms; robotic surgical procedures

Year:  2020        PMID: 32091305     DOI: 10.1097/JU.0000000000000811

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  A comparative analysis of single port versus multi-port robotic assisted radical prostatectomy for prostate cancer.

Authors:  Anna L Walsh; Prokar Dasgupta
Journal:  Investig Clin Urol       Date:  2020-06-17

2.  Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description.

Authors:  Tae Il Noh; Jong Hyun Tae; Ji Sung Shim; Seok Ho Kang; Jun Cheon; Jeong Gu Lee; Sung Gu Kang
Journal:  Prostate Int       Date:  2022-01-05

Review 3.  Robot-assisted radical prostatectomy: Advancements in surgical technique and perioperative care.

Authors:  Isaac Palma-Zamora; Firas Abdollah; Craig Rogers; Wooju Jeong
Journal:  Front Surg       Date:  2022-09-27

4.  Patient surgical satisfaction after da Vinci® single-port and multi-port robotic-assisted radical prostatectomy: propensity score-matched analysis.

Authors:  Jonathan Noël; Marcio Covas Moschovas; Marco Sandri; Seetharam Bhat; Travis Rogers; Sunil Reddy; Cathy Corder; Vipul Patel
Journal:  J Robot Surg       Date:  2021-06-18

5.  Single Incision Robotic Cystectomy and Hybrid Orthotopic Neobladder Reconstruction: A Step by Step Description.

Authors:  Mark Tyson; Paul Andrews; Scott Cheney; Mitchell Humphreys
Journal:  Urology       Date:  2021-07-15       Impact factor: 2.633

Review 6.  Single-Port versus Multiple-Port Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis.

Authors:  Omar Fahmy; Usama A Fahmy; Nabil A Alhakamy; Mohd Ghani Khairul-Asri
Journal:  J Clin Med       Date:  2021-12-07       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.